Biolase (BIOL) Reports Q3 Loss of $0.09/Share

Biolase (NASDAQ: BIOL) reported Q3 EPS of ($0.09), versus ($0.08) reported last year. Revenue for the quarter came in at $11.2 million, versus $1.5 million reported last year.

For earnings history and earnings-related data on Biolase (BIOL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c